TCGA analysis of FERMT1 RNA expression levels revealed overexpression compared to normal samples (log RNA Seq Vs RSEM, Z-score threshold +/− 2.0) in lung, colorectal cholangiocarcinoma and hepatocellular carcinoma suggestive of potential oncogenic roles in these tumor types whilst a preponderance of downregulation of expression is observed in thyroid, kidney, breast, endometrial and prostate tumors indicating potential tumor suppressor roles in these tumor types (Supplementary Fig. 1C). Here, FERMT1 is linked to prostate neoplasm.